Skip to main content

progesterone (Prometrium®)

 

Following a limited submission

AWMSG advice

Status: Recommended

Progesterone (Prometrium®) is recommended for use in NHS Wales for the prevention of miscarriage in women presenting with bleeding in the first trimester of pregnancy and have a history of recurrent miscarriages.

This recommendation applies only in circumstances where the approved Welsh Patient Access Scheme (WPAS) is utilised or where the list / contract price is equivalent to or lower than the WPAS price.

 Recommendation and Decision Rationale: progesterone (Prometrium) 6820 (PDF, 44Kb)
 Evidence Summary Report: progesterone (Prometrium) 6820 (PDF, 103Kb)
 Equality and Health Impact Assessment: progesterone (Prometrium) 6820 (PDF, 160Kb)

Medicine details

Medicine name progesterone (Prometrium®)
Formulation 400 mg vaginal capsules
Reference number 6820
Indication

For the prevention of miscarriage in women presenting with bleeding in the first trimester of pregnancy and have a history of recurrent miscarriages  

Company Besins Healthcare UK Ltd
BNF chapter Obstetrics, gynaecology & urinary tract disorders
Assessment type Limited
Status Recommended
Scrutiny Panel meeting date 07/08/2025
LOWMAG meeting date 15/04/2026
AWMSG meeting date 20/05/2026
Date of issue 26/05/2026
Commercial arrangement WPAS
Follow AWTTC: